Based on emerging new evidence and expert consensus, a task force put together by the European League Against Rheumatism (EULAR) released updated recommendations for the management of systemic lupus erythematosus (SLE). This report was published in Annals of the Rheumatic Diseases.

The investigators performed a systematic review of studies focused on treatment strategies for the management of SLE published between January 2007 and December 2017. Recommendations for 4 broad categories were developed following the modified Delphi method, in which the task force devised related questions, elicited expert opinions, and reached consensus.

Goals for the treatment of SLE should aim to target remission of disease symptoms, prevention of damage from disease activity, minimization of drug side-effects, and improvement of quality of life measures. Close monitoring of disease activity and patient adherence to treatment are recommended to help reduce the risk for flare.

For full list of recommendations please click here.